Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2026)

Bionano Genomics' Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$700000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to -$700000.0; the TTM figure through Mar 2026 stood at -$700000.0 (down 103.19% YoY), while the FY2025 annual figure was -$2.6 million, down 110.44% from the prior year.
• Other Operating Expenses came in at -$700000.0 for Q1 2026 at Bionano Genomics, roughly flat from -$700000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $77.3 million in Q3 2023 to a low of -$700000.0 in Q1 2025.
• A 4-year average of $13.0 million and a median of $978000.0 in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 113.78% in 2025 and changed 0.0% in 2026, its largest moves.
• Bionano Genomics' Other Operating Expenses stood at $741000.0 in 2023, then tumbled by 81.38% to $138000.0 in 2024, then tumbled by 607.25% to -$700000.0 in 2025, then changed by 0.0% to -$700000.0 in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$700000.0, -$700000.0, and $138000.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison